COVID-19 Pandemic Coverage
XTalks
SEPTEMBER 14, 2020
CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. The package is made up of a €390 billion fund in grants and a €360 billion in low interest loans. And stimulus packages continue.
Let's personalize your content